Patient Square Capital LP

Q3 2025 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    24

  • Value ($000)

    $373,857

  • Date Filed
    11/10/2025
  • Form type
    13F-HR
  • CIK
    0001819257
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ROIVANT SCIENCES LTD

SHS
G76279101
$188.82 M
51 %

12,480,000

INSM
INSM

INSMED INC

COM PAR $.01
457669307
$47.00 M
13 %

326,400

EYPT
EYPT

EYEPOINT PHARMACEUTICALS INC

COM NEW
30233G209
$14.41 M
4 %

1,011,839

---

ABIVAX SA

SPONSORED ADS
00370M103
$12.89 M
3 %

151,833

CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
171757206
$11.59 M
3 %

121,000

ARGX
ARGX

ARGENX SE

SPONSORED ADR
04016X101
$11.43 M
3 %

15,500

LQDA
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$9.10 M
2 %

400,000

---

PHARVARIS N V

COM
N69605108
$8.62 M
2 %

345,381

OCUL
OCUL

OCULAR THERAPEUTIX INC

COM
67576A100
$8.36 M
2 %

715,000

MIRM
MIRM

MIRUM PHARMACEUTICALS INC

COM
604749101
$7.64 M
2 %

104,262

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 24